# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst John Ransom reiterates Encompass Health (NYSE:EHC) with a Strong Buy and raises the price target from ...
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $101 to...
Mizuho analyst Ann Hynes maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $93 to $95.
Encompass Health (NYSE:EHC) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $0.94 b...
Encompass Health Corp. (NYSE:EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation ho...